Fig. 4From: Challenges and perspectives of tendon-derived cell therapy for tendinopathy: from bench to bedsideProposed method to reprogram tendon cells from aged to rejuvenated. Aged tendon cell is possible to be reprogrammed to IPSC by Yamanaka factors and further induced to iMSC. There are two potential pathways for differentiation from iMSC to IPSC. IPSC, induced pluripotent stem cell. iMSC, IPSC-derived mesenchymal stem cellBack to article page